Pavel V. Ignatenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pavel V. Ignatenko has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Alexander A. Gostev
Meshalkin National Medical Research Center
18 shared publications - Olesia S. Osipova
National Medical Research Center named after Academician E.N. Meshalkin, Ministry of Health of the Russian Federation, 630055, Novosibirsk, Russian Federation
15 shared publications - Alexey V. Cheban
Meshalkin National Medical Research Center Novosibirsk Russian Federation
14 shared publications - Shoraan B. Saaya
Meshalkin National Medical Research Center
14 shared publications - Vladimir B. Starodubtsev
Meshalkin National Medical Research Center
9 shared publications - Andrey A. Karpenko
Meshalkin National Medical Research Center
8 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by South Ural State Medical University in Continuing Medical Education and Science
- Vol. 21 (2) , 3-10
Two-year results of endovascular and hybrid treatment of ilio-femoral artery segment
Background. This pilot randomized study will provide insight into the feasibility of endovascular and hybrid treatment for patients with combined iliac and femoral artery pathology. The aim of this pilot randomized study was to compare the two-year safety and efficacy of endovascular treatment (EVT) versus hybrid repair (HR) using an interwoven nitinol stent in patients with combined occlusive lesions of the iliac and common femoral arteries. Materials and methods. In the EVT group, after recanalization and balloon angioplasty of the iliac and common femoral arteries, it was implanted interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of the iliac arteries, as in the EVT group, but additionally underwent common femoral artery endarterectomy with xenopericardial patch angioplasty. Results. A total of 62 patients were randomized (31 in the EVT group and 31 in the HR group). Mean length of hospital stay was shorter in the EVT group (p = 0.001). There were no deaths or major adverse cardiovascular events (MACE) within 30 days after surgery in either group. The 30-day perioperative complication rate was 9.7% in the EVT group versus 22.6% in the HR group (p = 0.17). Primary patency at 12 and 24 months was 81% and 60% in the EVT group, and 94% and 80% in the HR group (p = 0.12, p = 0.09). Secondary patency at 24 months was 90% in the EVT group versus 97% in the HT group (p = 0.27). Conclusions. This pilot study confirms that EVT and HR are comparable in terms of safety, although EVT shows a trend toward lower primary patency after 24 months of follow-up. A larger study is needed to confirm these findings.
- 23 July 2026
- Published by South Ural State Medical University in Continuing Medical Education and Science
- Vol. 21 (2) , 3-10
Open AccessTwo-year results of endovascular and hybrid treatment of ilio-femoral artery segment
Background. This pilot randomized study will provide insight into the feasibility of endovascular and hybrid treatment for patients with combined iliac and femoral artery pathology. The aim of this pilot randomized study was to compare the two-year safety and efficacy of endovascular treatment (EVT) versus hybrid repair (HR) using an interwoven nitinol stent in patients with combined occlusive lesions of the iliac and common femoral arteries. Materials and methods. In the EVT group, after recanalization and balloon angioplasty of the iliac and common femoral arteries, it was implanted interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of the iliac arteries, as in the EVT group, but additionally underwent common femoral artery endarterectomy with xenopericardial patch angioplasty. Results. A total of 62 patients were randomized (31 in the EVT group and 31 in the HR group). Mean length of hospital stay was shorter in the EVT group (p = 0.001). There were no deaths or major adverse cardiovascular events (MACE) within 30 days after surgery in either group. The 30-day perioperative complication rate was 9.7% in the EVT group versus 22.6% in the HR group (p = 0.17). Primary patency at 12 and 24 months was 81% and 60% in the EVT group, and 94% and 80% in the HR group (p = 0.12, p = 0.09). Secondary patency at 24 months was 90% in the EVT group versus 97% in the HT group (p = 0.27). Conclusions. This pilot study confirms that EVT and HR are comparable in terms of safety, although EVT shows a trend toward lower primary patency after 24 months of follow-up. A larger study is needed to confirm these findings.
- Open Access
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4474
Successful surgical reconstruction of a giant ruptured abdominal aortic aneurysm. A case report
In the era of national screening programs and the widespread availability of vascular ultrasound and multislice computed tomography, a giant abdominal aortic aneurysm with a diameter greater than 10 cm is a rare clinical finding. Delayed surgical treatment of a giant abdominal aneurysm leads to its rupture, with a mortality rate of <90%. Furthermore, performing both open and endovascular reconstructions presents a complex technical challenge for the treatment of this patient population. This article presents a case of successful aneurysmectomy in a patient with a giant ruptured juxtarenal abdominal aortic aneurysm. This case is considered unique due to the rarity of this pathology and the successful surgical outcome. This case highlights the importance of timely diagnosis, surgical intervention, and a multidisciplinary approach to achieving a favorable outcome in patients with a ruptured giant abdominal aortic aneurysm.
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4474
Open AccessSuccessful surgical reconstruction of a giant ruptured abdominal aortic aneurysm. A case report
In the era of national screening programs and the widespread availability of vascular ultrasound and multislice computed tomography, a giant abdominal aortic aneurysm with a diameter greater than 10 cm is a rare clinical finding. Delayed surgical treatment of a giant abdominal aneurysm leads to its rupture, with a mortality rate of <90%. Furthermore, performing both open and endovascular reconstructions presents a complex technical challenge for the treatment of this patient population. This article presents a case of successful aneurysmectomy in a patient with a giant ruptured juxtarenal abdominal aortic aneurysm. This case is considered unique due to the rarity of this pathology and the successful surgical outcome. This case highlights the importance of timely diagnosis, surgical intervention, and a multidisciplinary approach to achieving a favorable outcome in patients with a ruptured giant abdominal aortic aneurysm.
- Open Access
- 7 October 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (8) , 4414
Successful echocardiography-guided indirect right atrial thrombectomy in a pregnant patient: a case report
Floating thrombus in right heart indicates a high probability of pulmonary embolism, which can lead to severe consequences, including sudden death. Floating right heart thrombi in pregnant women are a rare but potentially dangerous complication that requires immediate treatment. The management of such patients requires an individual multidisciplinary approach taking into account the patient’s condition and thrombus characteristics. This article presents a case of successful thrombectomy in a 26-year-old patient in the second trimester of her second pregnancy with floating right atrial thrombosis. This case is unique due to the combination of following risk factors for thrombosis: pregnancy, genetic thrombophilia, and prior chronic thromboembolic pulmonary hypertension with pulmonary endarterectomy. A special feature of this case is successful indirect transjugular thrombectomy with echocardiography guidance as a less invasive alternative to open surgery or angiography-guided endovascular intervention, which minimized the risks of complications and achieved a favorable outcome. However, adherence to the proper interbirth interval and optimal anticoagulant prophylaxis in pregnancy would reduce the risks of thromboembolic events.
- 7 October 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (8) , 4414
Open AccessSuccessful echocardiography-guided indirect right atrial thrombectomy in a pregnant patient: a case report
Floating thrombus in right heart indicates a high probability of pulmonary embolism, which can lead to severe consequences, including sudden death. Floating right heart thrombi in pregnant women are a rare but potentially dangerous complication that requires immediate treatment. The management of such patients requires an individual multidisciplinary approach taking into account the patient’s condition and thrombus characteristics. This article presents a case of successful thrombectomy in a 26-year-old patient in the second trimester of her second pregnancy with floating right atrial thrombosis. This case is unique due to the combination of following risk factors for thrombosis: pregnancy, genetic thrombophilia, and prior chronic thromboembolic pulmonary hypertension with pulmonary endarterectomy. A special feature of this case is successful indirect transjugular thrombectomy with echocardiography guidance as a less invasive alternative to open surgery or angiography-guided endovascular intervention, which minimized the risks of complications and achieved a favorable outcome. However, adherence to the proper interbirth interval and optimal anticoagulant prophylaxis in pregnancy would reduce the risks of thromboembolic events.
- 2 June 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (2) , 1098-1106
Endovascular Treatment Versus Hybrid Repair for Iliofemoral Occlusive Disease: A Pilot Prospective Randomized Trial
Background: The treatment of patients with a simultaneous lesion of the iliac and common femoral arteries presents a significant challenge. Aim: The objective of pilot randomized trial (ClinicalTrials.gov) was to compare the short and 3‐year safety and efficacy of endovascular treatment (EVT) and hybrid repair (HR) procedures with using an interwoven nitinol stent for patients with coexisting iliac and common femoral occlusive disease. Materials and Methods: In the EVT group patients after recanalization and balloon angioplasty iliac and common femoral arteries were treated with interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of iliac arteries as in the EVT group but endarterectomy and patch angioplasty for the common femoral artery. Perioperative 1, 2, and 3‐year outcomes were compared between both groups. Results: Totally 62 patients were randomized (31 EVT and 31 HR). The average hospital length of stay was shorter in EVT group (3.9 ± 1.2 days EVT group vs. 7.9 ± 2.7 days HR group, p = 0.001). There were no mortalities, no MACEs in either group within 30 days post‐op. Thirty‐day perioperative morbidity rate was 9.7% in EVT group versus 22.6% in HR group ( p = 0.17). The primary patency rate at 12, 24 and 36 months was 81%, 60%, and 46% in the EVT group, 94%, 80%, and 73% in the HR group ( p = 0.12, p = 0.09, and p = 0.03). The secondary patency rates at 36 months in EVT group was 83% versus 87% in HR group, respectively ( p = 0.64). Survival and limb salvage rates did not differ between groups at 36 months of follow‐up (93% vs. 93% p = 0.97% and 97% vs. 100% p = 0.31 respectively). Conclusions: This study supports that the hybrid treatment has an advantage over EVT in terms of safety and primary patency in the mid‐term follow‐up period. However, a larger study is needed to confirm these findings and further investigate the long‐term effects of the hybrid approach.
- 2 June 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (2) , 1098-1106
Endovascular Treatment Versus Hybrid Repair for Iliofemoral Occlusive Disease: A Pilot Prospective Randomized Trial
Background: The treatment of patients with a simultaneous lesion of the iliac and common femoral arteries presents a significant challenge. Aim: The objective of pilot randomized trial (ClinicalTrials.gov) was to compare the short and 3‐year safety and efficacy of endovascular treatment (EVT) and hybrid repair (HR) procedures with using an interwoven nitinol stent for patients with coexisting iliac and common femoral occlusive disease. Materials and Methods: In the EVT group patients after recanalization and balloon angioplasty iliac and common femoral arteries were treated with interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of iliac arteries as in the EVT group but endarterectomy and patch angioplasty for the common femoral artery. Perioperative 1, 2, and 3‐year outcomes were compared between both groups. Results: Totally 62 patients were randomized (31 EVT and 31 HR). The average hospital length of stay was shorter in EVT group (3.9 ± 1.2 days EVT group vs. 7.9 ± 2.7 days HR group, p = 0.001). There were no mortalities, no MACEs in either group within 30 days post‐op. Thirty‐day perioperative morbidity rate was 9.7% in EVT group versus 22.6% in HR group ( p = 0.17). The primary patency rate at 12, 24 and 36 months was 81%, 60%, and 46% in the EVT group, 94%, 80%, and 73% in the HR group ( p = 0.12, p = 0.09, and p = 0.03). The secondary patency rates at 36 months in EVT group was 83% versus 87% in HR group, respectively ( p = 0.64). Survival and limb salvage rates did not differ between groups at 36 months of follow‐up (93% vs. 93% p = 0.97% and 97% vs. 100% p = 0.31 respectively). Conclusions: This study supports that the hybrid treatment has an advantage over EVT in terms of safety and primary patency in the mid‐term follow‐up period. However, a larger study is needed to confirm these findings and further investigate the long‐term effects of the hybrid approach.
- Open Access
- 28 April 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (1) , 7-17
Asymptomatic cerebral ischemia after carotid artery stenting as a predictor of cognitive impairment
Objective: The study aimed to compare cognitive functions in patients with asymptomatic cerebral ischemic lesions and without cerebral ischemic lesions after carotid artery stenting (CAS). Methods: A prospective cohort study was based on a subanalysis of 100 patients from the SIBERIA study database who underwent CAS. Patients with a history of stroke or contralateral occlusion of the internal carotid artery, with the development of a vascular event or death during 12 months of follow-up, and individuals with lost contacts were excluded from the analysis. Patients completed the MMSE (Mini-Mental State Examination) test before and after CAS stenting at 6 and 12 months. All three tests were completed by 39 patients with asymptomatic cerebral ischemic lesions and 36 patients without cerebral ischemic lesions on diffusion-weighted magnetic resonance imaging (MRI) of the brain in the early postoperative period after CAS. Pseudo-randomization was performed in a 1:1 ratio using the propensity score matching method, after which 30 patients were included in each group. The primary endpoint was the development of predementia/dementia. Results: In the group patients with asymptomatic cerebral ischemic lesions, both a significantly lower median score on the MMSE test (26 [25; 28] versus 28 [28; 29], p < 0.001) and a greater number of patients with dementia/predementia (18 (60%) versus 7 (23.3%), p = 0.008) were found compared with the control group in 12 months after CAS. Asymptomatic cerebral ischemic lesions increased the risk of developing predementia/dementia within 12 months after CAS (RR 2.57 [1.07; 6.15], p = 0.02). The total volume of asymptomatic cerebral ischemic lesions ≥ 78 mm3 predicted a decline in cognitive functions. Conclusion: Asymptomatic cerebral ischemic lesions after CAS significantly increased the risk of developing cognitive impairment during 12 months after procedure. Received 20 February 2025. Revised 6 March 2025. Accepted 7 March 2025. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: O.S. Osipova,A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. ChernyavskiyData collection and analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovStatistical analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovDrafting the article: O.S. Osipova, A.A. GostevCritical revision of the article: P.V. Ignatenko,A.M. ChernyavskiyFinal approval of the version to be published: O.S. Osipova, A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. Chernyavskiy
- 28 April 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (1) , 7-17
Open AccessAsymptomatic cerebral ischemia after carotid artery stenting as a predictor of cognitive impairment
Objective: The study aimed to compare cognitive functions in patients with asymptomatic cerebral ischemic lesions and without cerebral ischemic lesions after carotid artery stenting (CAS). Methods: A prospective cohort study was based on a subanalysis of 100 patients from the SIBERIA study database who underwent CAS. Patients with a history of stroke or contralateral occlusion of the internal carotid artery, with the development of a vascular event or death during 12 months of follow-up, and individuals with lost contacts were excluded from the analysis. Patients completed the MMSE (Mini-Mental State Examination) test before and after CAS stenting at 6 and 12 months. All three tests were completed by 39 patients with asymptomatic cerebral ischemic lesions and 36 patients without cerebral ischemic lesions on diffusion-weighted magnetic resonance imaging (MRI) of the brain in the early postoperative period after CAS. Pseudo-randomization was performed in a 1:1 ratio using the propensity score matching method, after which 30 patients were included in each group. The primary endpoint was the development of predementia/dementia. Results: In the group patients with asymptomatic cerebral ischemic lesions, both a significantly lower median score on the MMSE test (26 [25; 28] versus 28 [28; 29], p < 0.001) and a greater number of patients with dementia/predementia (18 (60%) versus 7 (23.3%), p = 0.008) were found compared with the control group in 12 months after CAS. Asymptomatic cerebral ischemic lesions increased the risk of developing predementia/dementia within 12 months after CAS (RR 2.57 [1.07; 6.15], p = 0.02). The total volume of asymptomatic cerebral ischemic lesions ≥ 78 mm3 predicted a decline in cognitive functions. Conclusion: Asymptomatic cerebral ischemic lesions after CAS significantly increased the risk of developing cognitive impairment during 12 months after procedure. Received 20 February 2025. Revised 6 March 2025. Accepted 7 March 2025. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: O.S. Osipova,A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. ChernyavskiyData collection and analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovStatistical analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovDrafting the article: O.S. Osipova, A.A. GostevCritical revision of the article: P.V. Ignatenko,A.M. ChernyavskiyFinal approval of the version to be published: O.S. Osipova, A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. Chernyavskiy
- 4 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (5) , 603-616
Interwoven Nitinol Stent Versus Laser-Cut-Type Nitinol Stent for Long Femoropopliteal Occlusive Disease: A Propensity Matched Analysis
Purpose There are still limited data to determine the efficacy of interwoven nitinol stent (INS) compared with laser-cut nitinol stent (CNS) for the endovascular treatment of long femoropopliteal lesions. The aim of this study is to evaluate the short- and mid-term results of the effectiveness of CNS and INS in the revascularization of long femoropopliteal occlusions. We performed analyses of the primary and secondary outcome measures for subgroups of patients with below-the-knee and “above-the-knee” lesions. Materials and Methods A retrospective propensity matched analysis was conducted on symptomatic patients (Rutherford category 3–6) with long occlusions of the femoropopliteal segment (> 15 cm) who underwent stenting with either INS or CNS from 2012 to 2020. The primary outcome measure was the primary patency in 2 years. Secondary outcome measures were secondary patency, major adverse cardiovascular events, major adverse limb events, sustained clinical improvement, and mortality. Results After propensity score matching, 126 and 125 patients remained in the INS and CNS groups, respectively. There were no cases of major cardiovascular events (MACE) or major limb events in both groups during the perioperative period. There were no significant differences in primary and secondary patency during a 2-year follow-up. There were no stent fractures in the INS group, whereas in the CNS group the stent fractures rate reached 37 (29.6%) patients (p < 0.001). In the “above-the-knee” subgroup, INS and CNS showed comparable primary patency rates. However, the secondary patency rates were 82.0% and 96.9% in INS and CNS groups, respectively (p < 0.001). The secondary sustained clinical improvement rates were 79.8% and 93.9% in INS and CNS subgroups, respectively (p < 0.001). In the “below-the-knee subgroup,” INS showed higher primary patency rate (INS: 64.9% CNS: 37.1%; p = 0.04). In the CNS group, the fractures rate “below the knee” was statistically significantly higher compared with stents “above the knee” (p = 0.03). Conclusion After propensity score matching, INS showed comparable results with CNS for the whole cohort. However, INS seems to achieve better outcomes for femoropopliteal lesion extended to the below-the-knee level. Graphical Abstract
- 4 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (5) , 603-616
Interwoven Nitinol Stent Versus Laser-Cut-Type Nitinol Stent for Long Femoropopliteal Occlusive Disease: A Propensity Matched Analysis
Purpose There are still limited data to determine the efficacy of interwoven nitinol stent (INS) compared with laser-cut nitinol stent (CNS) for the endovascular treatment of long femoropopliteal lesions. The aim of this study is to evaluate the short- and mid-term results of the effectiveness of CNS and INS in the revascularization of long femoropopliteal occlusions. We performed analyses of the primary and secondary outcome measures for subgroups of patients with below-the-knee and “above-the-knee” lesions. Materials and Methods A retrospective propensity matched analysis was conducted on symptomatic patients (Rutherford category 3–6) with long occlusions of the femoropopliteal segment (> 15 cm) who underwent stenting with either INS or CNS from 2012 to 2020. The primary outcome measure was the primary patency in 2 years. Secondary outcome measures were secondary patency, major adverse cardiovascular events, major adverse limb events, sustained clinical improvement, and mortality. Results After propensity score matching, 126 and 125 patients remained in the INS and CNS groups, respectively. There were no cases of major cardiovascular events (MACE) or major limb events in both groups during the perioperative period. There were no significant differences in primary and secondary patency during a 2-year follow-up. There were no stent fractures in the INS group, whereas in the CNS group the stent fractures rate reached 37 (29.6%) patients (p < 0.001). In the “above-the-knee” subgroup, INS and CNS showed comparable primary patency rates. However, the secondary patency rates were 82.0% and 96.9% in INS and CNS groups, respectively (p < 0.001). The secondary sustained clinical improvement rates were 79.8% and 93.9% in INS and CNS subgroups, respectively (p < 0.001). In the “below-the-knee subgroup,” INS showed higher primary patency rate (INS: 64.9% CNS: 37.1%; p = 0.04). In the CNS group, the fractures rate “below the knee” was statistically significantly higher compared with stents “above the knee” (p = 0.03). Conclusion After propensity score matching, INS showed comparable results with CNS for the whole cohort. However, INS seems to achieve better outcomes for femoropopliteal lesion extended to the below-the-knee level. Graphical Abstract
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (4)
Comparative analysis of endovascular and open surgical treatment of aortoiliac bifurcation lesions
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (4)
Comparative analysis of endovascular and open surgical treatment of aortoiliac bifurcation lesions
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (3) , 102-110
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
Эндоваскулярные и гибридные вмешательства при стено-окклюзионных поражениях подвздошно-бедренного сегмента (пилотное проспективное рандомизированное
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (3) , 102-110
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
Эндоваскулярные и гибридные вмешательства при стено-окклюзионных поражениях подвздошно-бедренного сегмента (пилотное проспективное рандомизированное
- Open Access
- 8 December 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (11) , 5284
Russian consensus statement on the diagnosis and treatment of patients with carotid stenosis
Carotid stenosis is a multidisciplinary problem that requires the involvement of a specialists’ team, including cardiovascular surgeons, neurosurgeons, endovascular surgeons, cardiologists, neurologists, and internists. In this consensus statement, a group of experts considered the main stages of diagnosing carotid stenosis, as well as discussed, the necessary prevention methods and features of choosing the optimal treatment approach. The aim was to provide concise and structured information on the management of patients with carotid stenosis. This document was developed based on the updated clinical guidelines of the European Society for Vascular Surgery and the American Association for Vascular Surgery, taking into account the consensus opinion of Russian experts.
- 8 December 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (11) , 5284
Open AccessRussian consensus statement on the diagnosis and treatment of patients with carotid stenosis
Carotid stenosis is a multidisciplinary problem that requires the involvement of a specialists’ team, including cardiovascular surgeons, neurosurgeons, endovascular surgeons, cardiologists, neurologists, and internists. In this consensus statement, a group of experts considered the main stages of diagnosing carotid stenosis, as well as discussed, the necessary prevention methods and features of choosing the optimal treatment approach. The aim was to provide concise and structured information on the management of patients with carotid stenosis. This document was developed based on the updated clinical guidelines of the European Society for Vascular Surgery and the American Association for Vascular Surgery, taking into account the consensus opinion of Russian experts.